Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats:...

Area of Science:

• Neuroscience
• Pharmacology
• Neurobiology

Background:

• Opiate withdrawal causes neuronal morphological changes and spine density reduction in the nucleus accumbens.
• Withania somnifera (Ashwagandha) is a medicinal herb with demonstrated neuroprotective and neuritic regeneration properties.
• Withania somnifera constituents, like withanolides, are investigated for their potential in neurological disorder treatment.

Purpose of the Study:

• To investigate the effect of Withania somnifera extract on morphine withdrawal-induced spine density reduction in the nucleus accumbens.
• To determine if Withania somnifera administration during chronic morphine treatment or during withdrawal impacts withdrawal severity and neuronal structure.

Main Methods:

• Rats received chronic Withania somnifera extract with morphine or saline.
• Spontaneous and pharmacologically precipitated withdrawal models were used.
• Brain tissue was processed using Golgi-Cox staining for confocal microscopic examination of spine density in the nucleus accumbens.

Main Results:

• Withania somnifera extract reduced withdrawal syndrome severity when administered during chronic morphine treatment, but not during withdrawal.
• Pretreatment with Withania somnifera extract fully prevented the reduction of spine density in the nucleus accumbens shell during both spontaneous and precipitated withdrawal.
• No significant effect on spine density was observed when Withania somnifera was administered only during the withdrawal phase.

Conclusions:

• Pretreatment with Withania somnifera extract protects against the structural neuroadaptations associated with morphine withdrawal.
• Withania somnifera demonstrates potential therapeutic benefits in mitigating the consequences of opiate withdrawal.
• The findings suggest a neuroprotective role for Withania somnifera in opiate dependence and withdrawal.